ETHICA
Ethica Clinical Research Inc.
Application Filed: 2003-07-22
Trademark Application Details
REGISTERED AND RENEWED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 78277322 |
| Registration Number | 3188634 |
| Mark Drawing Code | 1000: Typeset: Word(s)/letter(s)/number(s) |
| Domestic Representative | Wendy Boldt Cohen |
| Attorney Name | Dan S. Cohn |
| Attorney Docket Number | 715382.1037 |
| Law Office Assigned | L90 |
| Employee Name | ANKRAH, NAAKWAMA S |
Timeline
| 2002-09-01 | Date of First Use |
| 2003-07-22 | Application Filed |
| 2006-10-10 | Published for Opposition |
| 2006-12-26 | Trademark Registered |
| 2016-12-26 | Renewal Date |
| 2017-02-23 | Location: GENERIC WEB UPDATE |
| 2017-02-23 | Status: Live/Registered |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Ethica Clinical Research Inc. |
| Address | 8555 Transcanada Highway Suite 201 Montreal, Quebec CA H4S1Z6 |
| Legal Entity Type | Corporation |
| Legal Entity State | CA |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 35 |
| U.S. Codes: | 100,101,102 |
| International Codes: | 41 |
| U.S. Codes: | 100,101,107 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0351 | Clinical trial supplies management services, namely-customized drug packaging and labeling, central and site administered randomization and study supply distribution; developing and managing distribution and storage logistics for all clinical supplies, namely study drugs and devices, case report forms, study binders and all study related documentation; clinical trial management services, namely-pre-study document collection and review, site selection, pre-study site visits, initiation visits, monitoring visits, close-out visits, project tracking and monitoring reports, negotiation and administration of investigator grants, labeling, packaging, distribution, coordination and tracking of clinical trial materials, regulatory document processing, central laboratory selection and coordination; managing site and study-specific subject recruitment strategies and programs, namely contingency strategies and solutions to address specific project challenges; managing the development of all study related documents and materials, namely study protocols, amendments, paper and electronic case report forms, and informed consent forms; managing study operations/monitoring manuals in accordance with data management conventions, web-based data listings, namely adverse events, enrollment status, efficacy endpoints and paper and electronic study newsletters; management of tracking tools for enrollment, essential documents, monitoring, subject and case report form tracking, drug accountability, data queries and adverse events; managing all aspects of study drug reconciliation and inventory and distribution reports; managing all aspects of clinical trials, namely managing investigators, technicians, and participants, ethical reviews, investigator meetings, databases, statistical analyses and reporting, randomization logistics, medical writing services; recruitment of investigators, technicians and participants; providing strategies for recruitment of participants |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| TEAS AMENDMENT OF USE RECEIVED | 2003-09-10 | 1 EAAU I:Incoming Correspondence |
| USE AMENDMENT FILED | 2003-09-10 | 2 IUAF S: |
| AMENDMENT TO USE PROCESSING COMPLETE | 2003-09-17 | 3 AUPC I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2004-01-12 | 4 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION E-MAILED | 2004-01-27 | 5 GNRT F:First Action |
| PAPER RECEIVED | 2004-07-30 | 6 MAIL I:Incoming Correspondence |
| ASSIGNED TO LIE | 2004-08-09 | 7 ALIE A:Allowance for Publication |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2004-07-26 | 8 CRFA I:Incoming Correspondence |
| AMENDMENT FROM APPLICANT ENTERED | 2004-08-09 | 9 ACEC I:Incoming Correspondence |
| ASSIGNED TO LIE | 2004-08-12 | 10 ALIE A:Allowance for Publication |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2004-07-30 | 11 CRFA I:Incoming Correspondence |
| AMENDMENT FROM APPLICANT ENTERED | 2004-08-12 | 12 ACEC I:Incoming Correspondence |
| SUSPENSION LETTER WRITTEN | 2004-09-09 | 13 CNSL R:Renewal |
| LETTER OF SUSPENSION E-MAILED | 2004-09-09 | 14 GNSL S: |
| LIE CHECKED SUSP - TO ATTY FOR ACTION | 2005-03-10 | 15 RCCK S: |
| SUSPENSION INQUIRY WRITTEN | 2005-04-11 | 16 CNSI R:Renewal |
| INQUIRY TO SUSPENSION E-MAILED | 2005-04-11 | 17 GNSI S: |
| FAX RECEIVED | 2005-04-29 | 18 FAXX I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2005-04-29 | 19 CRFA I:Incoming Correspondence |
| AMENDMENT FROM APPLICANT ENTERED | 2005-05-18 | 20 ACEC I:Incoming Correspondence |
| USE AMENDMENT ACCEPTED | 2005-05-20 | 21 IUAA P: |
| FINAL REFUSAL WRITTEN | 2005-06-13 | 22 CNFR R:Renewal |
| FINAL REFUSAL E-MAILED | 2005-06-13 | 23 GNFR O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2005-12-13 | 24 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2005-12-13 | 25 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2005-12-21 | 26 TEME I:Incoming Correspondence |
| EXPARTE APPEAL RECEIVED AT TTAB | 2005-12-22 | 27 EXAF T:TTAB Proceeding |
| JURISDICTION RESTORED TO EXAMINING ATTORNEY | 2005-12-28 | 28 JURT T:TTAB Proceeding |
| EX PARTE APPEAL-INSTITUTED | 2005-12-28 | 29 EXPI T:TTAB Proceeding |
| ACTION CONTINUING FINAL - COMPLETED | 2006-02-15 | 30 CNCF S: |
| ACTION DENYING REQ FOR RECON E-MAILED | 2006-02-15 | 31 GECD O:Outgoing Correspondence |
| EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED | 2006-05-15 | 32 CPEA R:Renewal |
| EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | 2006-05-15 | 33 GEAP O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2006-06-13 | 34 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2006-06-13 | 35 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2006-07-12 | 36 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2006-08-01 | 37 CNSA O:Outgoing Correspondence |
| ASSIGNED TO LIE | 2006-08-11 | 38 ALIE A:Allowance for Publication |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2006-08-18 | 39 PREV O:Outgoing Correspondence |
| NOTICE OF PUBLICATION | 2006-09-20 | 40 NPUB O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 2006-10-10 | 41 PUBO A:Allowance for Publication |
| REGISTERED-PRINCIPAL REGISTER | 2006-12-26 | 42 R.PR A:Allowance for Publication |
| EXPARTE APPEAL TERMINATED | 2007-01-29 | 43 EXPT T:TTAB Proceeding |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2009-11-23 | 44 COAR I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2009-11-23 | 45 CHAN I:Incoming Correspondence |
| TEAS SECTION 8 & 15 RECEIVED | 2012-12-20 | 46 E815 I:Incoming Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2013-01-15 | 47 APRE A:Allowance for Publication |
| REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | 2013-01-15 | 48 C15A O:Outgoing Correspondence |
| NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | 2013-01-16 | 49 NA85 E:E-Mail |
| COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | 2015-12-26 | 50 REM2 E:E-Mail |
| TEAS SECTION 8 & 9 RECEIVED | 2016-12-22 | 51 E89R I:Incoming Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2017-02-23 | 52 APRE A:Allowance for Publication |
| REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | 2017-02-23 | 53 89AG O:Outgoing Correspondence |
| REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | 2017-02-23 | 54 RNL1 Q: |
| NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | 2017-02-23 | 55 NA89 E:E-Mail |
| AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | 2023-09-20 | 56 ASGN I:Incoming Correspondence |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 